Hi everyone,In this new episode of The Illusion of Consensus podcast, I interview Charles Rixey, a member of the group DRASTIC, which has been investigating the origins of the COVID-19 virus. They discuss the efforts by scientific leaders, such as Tony Fauci, to suppress the lab leak theory and create an illusion of consensus around the natural origin theory. DRASTIC, a group of citizen scientists, uncovered evidence that challenged the natural origin narrative, including deleted sequences from the Wuhan lab's viral database. The conversation emphasizes the importance of uncovering the truth and restoring trust in science and medicine.Our exciting first podcast sponsor:Alcami Elements - a premium herbal supplement for energy, focus, and concentration. Alcami contains 9 high-quality adaptogens that can help regulate your nervous system and optimize energy and focus. Adaptogens are herbs and mushrooms that help build the body’s resilience to stress.Get 10% off your first order or 30% off a monthly subscription using the code "illusion” here:https://www.alcamielements.com/products/alcami-elements-life-enhancing-beverageChapters00:00 Introduction and Background03:12 Unscrupulous Scientific Leaders and Motives11:02 The Importance of Furin Cleavage Site12:30 The Significance of ACE2 Receptor and Furin Cleavage Site15:50 Debate Among Molecular Geneticists25:57 Formation and Work of DRASTIC29:46 Access to Wuhan Lab Sequences40:53 The Michael Warby Paper and Flaws43:52 Questioning the Accuracy of Chinese Data48:44 The Lancet Commission and Jeffrey Sachs55:31 Evidence of a Lab Leak: The Diffuse Proposal01:02:12 History of Gain-of-Function Research01:15:10 The Implications for Future Pandemic Preparedness01:20:15 The Collapse of Trust in ScienceConsider helping us fund our podcast expansion as we seek to hire a producer and video editor:https://donorbox.org/help-fund-independent-journalism-2 This is a public episode. If you’d like to discuss this with other subscribers or get access to bonus episodes, visit www.illusionconsensus.com/subscribe